“…The exclusion criteria were recurrent acute CSC with poor VA, previous acute CSC in the fellow eye with subnormal visual outcome, history of other retinal disease, significant ocular media opacity with possible progression within 6 months, previous ocular surgery within 6 months, previous macular laser treatment, steroid use, pregnancy, and allergy to fluorescein dye. The sample size of this study was based on previous prospective studies of CSC [ 6 , 9 , 13 ]. The study protocol was reviewed and approved by the Ethics Committee of the Faculty of Medicine, Prince of Songkla University.…”